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Lysosomal degradation of the receptor-tyrosine kinase cMet
requires receptor ubiquitination by the E3 ubiquitin ligase Cbl fol-
lowed by clathrin-dependent internalization. A role for Cbl as an
adaptor for cMet internalization has been previously reported.
However, the requirement for Cbl ubiquitin ligase activity in this
process and its mode of recruitment to cMet has yet to be deter-
mined.CblcandirectlybindcMetatphosphotyrosine1003or indi-
rectly via Grb2 to phosphotyrosine 1356 in the multisubstrate
binding domain of cMet. The direct binding of Cbl with cMet is
critical for receptor degradation and not receptor internalization.
Hereweshowastrict requirement forGrb2andtheubiquitin ligase
activity of Cbl for cMet endocytosis. Receptor internalization was
impaired by small interfering RNAdepletion of Grb2, overexpres-
sion of dominant negative Grb2 mutants, and point mutations in
the cMet multisubstrate docking site that inhibits the direct asso-
ciation of Grb2 with cMet. The requirement for Grb2 was specific
and did not involve the multiadaptor Gab1. cMet internalization
was impaired in cells expressing an ubiquitin ligase-deficient Cbl
mutant or conjugation-deficient ubiquitin but was unaffected in
cells expressing a Cbl mutant that is unable to bind cMet directly.
Expression of aCbl-Grb2 chimera rescued impaired cMet endocy-
tosis in cells depleted of endogenous Grb2. These results indicate
that the ubiquitin ligase activity of Cbl is critical for clathrin-de-
pendent cMet internalization and suggest a role for Grb2 as an
intermediary linking Cbl ubiquitin ligase activity to this process.
Activation of the receptor-tyrosine kinase (RTK)2 cMet by
binding to its physiological ligand hepatocyte growth factor
(HGF) results in increased cell proliferation and cell motility,
processes critical for embryonic development, tissue regenera-
tion, and homoeostasis (for review, see Ref. 1). Persistent cMet
signaling occurs in many human cancers, correlating closely
with early stage invasion, dissemination, and metastases (for
review, see Refs. 1 and 2). Once activated by ligand binding,
cMet is normally endocytosed exclusively through clathrin-
coated pits (3, 4) and then inactivated by lysosomal degradation
(3, 5). Although several mechanisms likely contribute to sus-
tained cMet signaling in cancer (6–12), dysregulated receptor
internalization and degradation have recently emerged as novel
mechanisms for cMet-induced cell transformation and the
increased neoplastic growth of human tumors (13–16).
Endocytic studies on other RTKs, most notably the epider-
mal growth factor receptor (EGFR), suggest that modification
of the endocytic traffickingmachinery by the activated receptor
and/or its associated signaling molecules regulates receptor
internalization and degradation. For example, the signaling
adaptor Grb2 has been shown to function as an important ini-
tiator of EGFR endocytosis (17–20). Small interfering RNA
(siRNA)-mediated depletion of Grb2 and overexpression of
Grb2-SH3 mutants deficient in binding downstream signaling
molecules blocks the recruitment of EGFR into clathrin-coated
pits and subsequent receptor internalization, with negligible
effects on the downstream activation ofmitogen-activated pro-
tein kinase or phosphatidylinositol 3-kinase (19). Grb2 func-
tions to regulate EGFR internalization through the recruitment
of the E3 ubiquitin ligase Cbl (20–22). However, it remains
unclear if the requirement for Grb2 on EGFR endocytosis is
mediated solely through interactions with Cbl, functions at the
level of EGFR ubiquitination, involves additional Grb2-
dependent interactions, or extends to other RTKs.
cMet and the EGFR are prototypicmembers for distinct RTK
subfamilies and as such exhibit unique structural and func-
tional characteristics. In contrast to the EGFR, cMet is a het-
erodimer composed of an extracellular chain that is disulfide-
linked to a transmembrane  chain that contains cytoplasmic
tyrosine kinase activity (23–25). The extracellular domain of
cMet contains a distinctive -propeller fold that mediates
ligand binding (26). Ligand binding induces the autophospho-
rylation of cMet and EGFR atmultiple tyrosines in their respec-
tive C-terminal regions enabling the recruitment and subse-
quent activation of shared downstream adaptor and signaling
molecules. The EGFR possesses six tyrosine transphosphoryla-
tion sites dispersed throughout the C-terminal region (for
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review, see Ref. 27), whereas cMet contains two key tyrosine
phosphorylation sites at positions 1349 and 1356 in a unique
multisubstrate-docking site, that function to concomitantly
activate multiple downstream signaling pathways (28, 29). In
contrast to cMet, which contains one binding site for the sig-
naling adaptor Grb2 at phosphotyrosine 1356 (28, 30), Grb2
binds EGFR directly at two sites (31). Moreover, Grb2 appears
to play a minor role in signaling events downstream of ligand
activated cMet in vivo (32–34) when compared with the EGFR
(34). The adaptor protein Gab1 binds to two sites in the multi-
substrate-docking site of cMet; directly at phosphotyrosine
1349 or indirectly via the adaptor Grb2 to phosphotyrosine
1356 (35–38). Gab1 recruitment is essential for the induction
of cell motility, branching morphogenesis, and the forma-
tion of crypts in three-dimensional matrices, hallmarks of
cMet signaling (29, 33, 39–41). Given these differences in
adaptor recruitment and biological activity, some differ-
ences may exist in the regulatory mechanisms controlling
cMet versus EGFR internalization.
The E3 ubiquitin ligase Cbl has been shown to mediate the
ubiquitination of ligand-activated cMet (4, 5, 14, 42, 43), recep-
tor internalization (4), and degradation (13, 14). Cbl recruit-
ment via its tyrosine kinase binding domain to phosphotyrosine
1003 of cMet has been shown to contribute to receptor ubiq-
uitination (13, 14, 42) and degradation in lysosomes (13, 14, 43).
Cbl has been shown to function as an adaptor important for
cMet internalization through clathrin-coated pits via the
recruitment of the endophilin-CIN85 complex (4). However,
a requirement for Cbl ubiquitin ligase activity and its mode
of recruitment for cMet internalization was not examined. In
this study we report that the ubiquitin ligase activity of Cbl is
important for clathrin-mediated cMet internalization. More-
over, Grb2 bound directly to the cMet multisubstrate docking
site acts as an intermediary for Cbl ubiquitin ligase activity in
these events.
EXPERIMENTAL PROCEDURES
Reagents, Antibodies, and Plasmids—All general reagents
were obtained from Fisher or Sigma-Aldrich unless indi-
cated otherwise. Recombinant human HGF was purchased
from PeproTech Inc, Rocky Hill, NJ. EZ-link sulfo-NHS-SS-
biotin, D-salt dextran, and spin columns were purchased from
Pierce. Texas Red-labeled-transferrin (Tfn) and antibody label-
ing kits were obtained from Invitrogen. The following antibod-
ies were purchased as indicated; Shc (BD Biosciences), anti-
humanHGF (R&D Systems Inc, Minneapolis, MN), transferrin
receptor (Invitrogen), anti--actin and anti-phosphotyrosine
clone PY-20 (Sigma-Aldrich), ubiquitin (P4D1), Cbl (C-15),
Grb2 (C-23), cMet C-12, and cMet C-28 (Santa Cruz Biotech-
nologies), anti-Gab1 CT, phospho-Met Tyr-1234, Tyr-1235
(UpState Biotechnology), Gab1, phospho-Gab1, c-Jun N-ter-
minal kinase (JNK), phospho-JNK, p42/p44 MAPK, phospho
p42/p44, MEK (mitogen-activated protein kinase/extracellular
signal-regulated kinase kinase), and phospho-MEK (Cell Sig-
naling Technology), the monoclonal GFP antibody (JL-8) (BD
Biosciences Clontech), peroxidase-conjugated goat anti-mouse
immunoglobulin G (IgG) and goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, Inc.), andAlexa488 orAlexa594-
labeled goat anti-mouse, anti-rabbit, or anti-rat secondary anti-
bodies (Invitrogen). A pLXSNplasmid encodingwild type (wt)-
cMet was previously reported (44). pLXSN plasmids encoding
the full-lengthMetmutants N1358H and Y1349F,Y1356F were
generously provided by Pascal Peschard and Morag Park
(McGill University). The K1110A allele encodes aMet receptor
lacking kinase activity (45, 46). The K1110Amutation was gen-
erated through a PCR-based SOEing approach (47) using wild
type cMet cDNA as a template, Pfu DNA polymerase, and the
primers 5-CAAGCTAGCCACAGCACAGTG-3, 5-CCCA-
TCCTAACTAGTGGGGAC-3, 5-CACTGTGCTGTGGCT-
AGCTTG-3, and 5-GCTCTAGAACTAGTGGATCCC-3.
The final 1.3-kilobase PCR product was subcloned between
the SpeI and XcmI sites of pLXSN-Met-wt, resulting in a full-
length Met gene with the K1110A mutation and verified by
DNA sequencing. The variousMet alleles were subcloned from
the plasmid pLXSN into the murine stem cell virus vector
pMSCVpuro (BD Biosciences) for retroviral-mediated trans-
fection in the target cell lines. pYFP-N1 plasmids encoding
Grb2 and Grb2-mSH3 were kindly provided by Lawrence
Samelson (National Institutes of Health) (48). The pEGFP plas-
mids encoding Cbl, Cbl-SH2, Cbl-SH2/R86A, Grb2-SH2,
and Grb2/R86A were kindly provided by Alexander Sorkin
(University of Colorado Health Sciences Center) (17, 22).
pcDNA3-Myc-UbR and pcDNA3-Myc-UbRL8A/I44A were
kind gifts from Inger Madshus (Norwegian Radium Hospital)
(18). Plasmids encoding hemagglutinin-tagged Cbl (wt), 70Z-
Cbl, and Cbl-G306E were kindly provided by Jannie Borst (The
Netherlands Cancer Institute) (20).
Cell Lines—The H10 cell line derived from kidney epithelial
cells from embryos of cMet null/mice (49) was a generous
gift of Dr. Lloyd Cantley (Yale University School of Medicine).
Polyclonal H10 cell lines expressing cMet alleles were gener-
ated by retroviral transfection essentially as described (50),
except that 1–5 g/ml puromycin was used for selection, and
limiting dilution was not performed. Cell lines were analyzed
for cMet expression by Western blotting with the anti-cMet
antibody DL-21 (Upstate Biotechnology), and those cell lines
that exhibited similar cMet levels were chosen for further anal-
ysis. The parental H10 cMet null/ cell line was maintained
in Dulbecco’s modified Eagle’s medium/F-12(1:1) with 10%
fetal bovine serum. H10 derivatives stably expressing wild type
or mutant cMet alleles were grown in the same medium con-
taining 5 g/ml puromycin. Human mammary epithelial cells
(T47D) stably expressing full-length human cMet (T47D/
cMet) were a generous gift of Morag Park (McGill University)
and were maintained in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum supplemented with 400
g/ml G418.
siRNAs and Cell Transfections—For siRNAs depletion stud-
ies, cells were grown on coverslips in 60-mm plates and trans-
fected with SmartpoolsTM containing four siRNA duplexes for
Gab1, Grb2, Shc, or a control siRNA using Lipofectamine 2000
reagent (Invitrogen). Typically each coverslip of cells was trans-
fected with 200 pmol of siRNA and 8l of Lipofectamine 2000.
T47D/cMet cells were routinely cultured on coverslips coated
with 100 g/ml polylysine before experimentation. All experi-
ments were routinely performed 72 h after siRNA transfection.
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Cell transfections using plasmids were performed as previously
described (3).
Immunoprecipitation and GST Pulldown Assays—For
immunoprecipitation (IP) studies cells were washed twice with
ice-cold PBS (137mMNaCl, 2.7 mM KCl, 8.2 mMNa2HPO4, 1.5
mM KH2PO4) and lysed on ice in radioimmune precipitation
assay buffer (50 mM Tris-HCl, pH 7.4, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 1 mM EDTA)
with protease inhibitors (2g/ml aprotinin, 2g/ml leupeptin,
2 g/ml pepstatin) and phosphatase inhibitors (10 mM NaF, 2
mM Na3VO4). Cell lysates were cleared by centrifugation at
12,000  g at 4 °C, and then 500–1000 g of each lysate was
incubated with 5 g of primary antibody overnight at 4 °C.
Antibody-protein complexes were precipitated with 50 l of
protein A/G-agarose solution (Pierce) by rotation at 4 °C for
4 h. The protein-beads complex were collected by centrifuga-
tion at 1000 g for 5 min, washed with lysis buffer 3 times, and
then resuspended in SDS loading buffer and fractionated by
SDS/PAGE. For GST pulldown assays, the cell lysates were pre-
pared in lysis buffer (1%Triton X-100, 50mMTris-HCl, pH 7.4,
150mMNaCl, 2mM EDTA, 2g/ml aprotinin, 2g/ml leupep-
tin, 2 g/ml pepstatin, 10 mM NaF, 2 mM Na3VO4). Lysates
(0.5–1.0 mg of protein) were incubated with the appropriate
GST fusion proteins prebound to glutathione-Sepharose beads
(Sigma) overnight at 4 °C. Beads were washed three times in
lysis buffer followed by a final wash in 10 mM Tris-HCl, pH 7.4,
then analyzed by SDS/PAGE.
Cell Surface Biotinylation and Western Analysis—The bioti-
nylation and receptor internalization assays were described
previously (3). Briefly, cells were surface-biotinylated at 4 °C for
30 min with EZ-link NHS-SS-biotin (Pierce). Surface-ex-
pressed proteins were isolated directly using streptavidin-aga-
rose beads as described by the manufacturer (Pierce) and iden-
tified by Western analysis. Western analysis was performed
using ECL (GE Healthcare), and the resulting digitized blots
were quantified using AlphaEase Version 3.1.2 Software (Alpha
Innotech Corp.).
Flow Cytometry Analysis—cMet internalization from the
plasma membrane was measured by assaying the residual
amount of immunoreactive receptor accessible at the cell sur-
face to a monoclonal antibody recognizing an extracellular
epitope. Briefly, cells grown to 80% confluence on 60-mm
dishes were sera-starved for 4–6 h and then stimulated with
100 ng/ml internalin B (InlB) at 37 °C under steady state condi-
tions to drive cMet internalization. At the indicated times,
receptor endocytosis was terminated by placing the cells on ice.
The cells were immediately rinsedwith ice-cold PBS, and resid-
ual surface-bound InlB was stripped using three consecutive
5-min ice-cold acid washes (Dulbecco’s modified Eagle’s
medium, pH 3.5). Cells were detached with PBS containing 5
mM EDTA and then resuspended in ice-cold FACS buffer (PBS
containing 2% fetal bovine serum). Cells were incubated with
anti-cMet antibody (AF276, R&D System, MN) in FACS buffer
at 4 °C for 1 h, washed 3 times with ice-cold FACS buffer, and
then incubated with Alexa488-conjugated secondary antibody
in FACS buffer at 4 °C for 30 min. After 3 ice-cold washes with
FACS buffer, the cells were analyzed using a FACS Canto flow
cytometer or fixed with 2% paraformaldehyde, PBS for later
analysis. Cell viability, as determined by the exclusion of pro-
pidium iodide, routinely exceeded 95%. 20,000 cells were ana-
lyzed for each sample in triplicate for each condition in each
experiment. The mean fluorescence intensity (MFI) of the cells
at each time point was analyzed and compared with a negative
control using control antibody only. The MFI values for each
condition were averaged, and the S.E. was calculated across all
experiments. The relative percentage of residual cell surface
cMet at each timepoint (tx) was calculated relative to theMFI of
cells without internalization (t0) as (MFI txMFI control anti-
body only/MFI t0MFI control antibody only) 100.
InlB Labeling, ConfocalMicroscopy, andAnalysis—The puri-
fication and labeling of recombinant His6-tagged InlB has been
described in detail elsewhere (3). For confocal microscopy cells
grown on coverslips were incubated in media containing 5.0
g/ml Alexa594-labeled Tfn with 100 ng/ml InlB or HGF for 10
min at 37 °C, then fixed immediately after each experiment
using 4% paraformaldehyde (Ted Pella Inc.) in PBS. Residual
paraformaldehydewas quenched using 50mMNH4Cl/PBS, and
cells were then permeabilized with 0.05% (w/v) saponin (or
0.1% Triton X-100, PBS for HGF staining) for 20 min and then
blocked with 10% goat serum in PBS. All antibody dilutions
were performed in 5% goat serum, PBS with 0.05% saponin for
1 h. In studies staining for HGF, saponin was omitted from the
buffers. Coverslips were mounted and observed using a Zeiss
LSM 510 confocal microscope with a 63 oil (1.4 NA) immer-
sion objective. Samples were visualized with the 488- and
543-nm laser lines and emission filter sets at 505–530 nm for
YFP and Alexa488 detection or 585–615 nm for Texas Red and
Alexa594 detection, respectively. Figure presentation was
accomplished in Adobe Photoshop Version 6.0. Quantification
of co localization and internal fluorescence intensity were
accomplished using Metamorph v5.0 (Molecular Devices) as
described previously (3). All pixel intensity levels were normal-
ized relative to control values, expressed as a percentage S.E.,
and differences were statistically verified by analysis of variance
using GraphPad Prism Software (GraphPad Software Inc.).
RESULTS
The Tyrosine Kinase Activity and the Docking Site Phospho-
tyrosines 1349 and 1356 of cMet Are Required for Ligand-in-
duced Internalization—All of the known signaling cascades
downstream of activated cMet are mediated by autophospho-
rylation of two key tyrosines located at positions 1349 and 1356
in the novel multisubstrate docking site (28). To determine
whether autophosphorylation of these tyrosine residues is crit-
ical for cMet internalization, wt or mutant cMet was expressed
in cells immortalized from the kidneys of cMet null (/)
mice. These epithelial cMet/ cells undergo chemotaxis and
branching morphogenesis in response to EGF and transform-
ing growth factor- but not HGF, indicating that cMet signal-
ing is specifically abrogated in these cells (49). We generated
several cell lines stably expressing moderate levels of wt or
mutant cMet, including tyrosine kinase-deficient K1110A
cMet (KinD-cMet) and themultisubstrate-docking site mutant
Y1349F,Y1356F (YF-cMet), which is deficient in Gab1 and
Grb2 binding. siRNA-mediated depletion of clathrin heavy
chain inhibited wt cMet internalization (supplemental Fig. S1),
cMet Uptake Requires Grb2 and Cbl Ubiquitin Ligase Activity
16766 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282•NUMBER 23•JUNE 8, 2007
 at U
CF H
ealth Sciences Library on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
confirming that cMet internalization is clathrin-dependent in
these cells, consistent with our previous studies using T47D/
cMet and Vero cells (3).
We previously reported that the soluble form of the InlB
protein of Listeria monocytogenes mimics HGF-induced cMet
internalization and degradation (3). In addition to being pre-
sented as a soluble protein, InlB is also found anchored to the
cell surface of bacteria (51). The surface-anchored form of InlB
mediates bacterial uptake into host cells (5), whereas soluble
InlB is thought to modulate host transcriptional responses (52,
53). We previously reported that HGF and soluble InlB are
internalized with cMet via a clathrin-dependent mechanism
(3). Interestingly, evidence indicates that the internalization of
soluble InlB orHGFprobably occurs through amechanism that
differs from that utilized by bacteria expressing surface-an-
chored InlB.Although the uptake ofListeria and cMet activated
by soluble ligands involves select components of clathrin-
coated pits (5), Listeria entry requires phosphatidylinositol
3-kinase activity (54), whereas the internalization of soluble
HGFor InlB does not depend on this kinase (3). Because soluble
InlB and HGF are internalized through identical pathways, we
used InlB as an initial ligand to examine the molecular control
of cMet endocytosis and then validated key findings using the
physiological ligand HGF.
Western analysis of cell lysates prepared from the stable cell
lines expressing wt or mutant cMet confirmed that treatment
with InlB for 15 min at 37 °C caused phosphorylation of wt and
the YF-cMet mutant on tyrosine residues 1234 and 1235 in the
activation loop but not on kinase-dead cMet (KinD-cMet) (Fig.
1A). Ubiquitination of wt cMet but not KinD-cMet was
increased in response to InlB. A low level of ubiqitinated YF-
cMet was detected under these conditions, consistent with the
direct association of Cbl to phosphotyrosine 1003 of cMet,
independently of Grb2 binding (14). Cbl phosphorylation was
not detected in unstimulated cells or in cells stably expressing
KinD-cMet after treatment with ligand (Fig. 1A). In keeping
with previous results (14, 36), cMet-mediated phosphorylation
of Cbl was reduced in cells expressing YF-cMet relative to cells
expressing wt cMet. This is consistent with a role for Grb2 in
recruiting Cbl to cMet via phosphotyrosine 1356. Surface bioti-
nylation assays were used to confirm the cell surface expression
of wt and mutant cMet in each of the polyclonal cell lines (Fig.
1B). Cells were surface-biotinylated at 4 °C for 30 min using
NHS-SS-biotin. Cell lysates were then prepared, and biotiny-
lated proteins were isolated by streptavidin pulldown and ana-
lyzed by Western blots. Comparable levels of wt and mutant
cMet were detected at the cell surface of the cell lines (Fig. 1B).
No cMet was detected in the parental null cells, consistent with
previous reports (49).
Using a GST pulldown assay, we verified that Grb2 bound to
wt cMet in response to InlB but not to YF-cMet or KinD-cMet
(Fig. 1C). No Grb2 binding was detected in the absence of
ligand, confirming that Grb2 binding to wt cMet was specific
and dependent on cMet autophosphorylation. Similarly, Gab1
phosphorylation in response to InlB was detected in null cells
expressing wt cMet but not in cells expressing the YF- or KinD-
cMet mutants (Fig. 1D), consistent with previous reports using
fibroblasts andHEK293 cells (35, 55). Together, these data con-
firm that the recruitment of Gab1 and Grb2 to cMet is dis-
rupted in the YF- and KinD-cMet mutants but not in cells
expressing wt cMet.
We next examined ligand-induced internalization of wt and
mutant cMet using a flow cytometricmethod thatmeasures the
amount of immunoreactive receptor remaining on the cell sur-
face after ligand treatment. Briefly, cMet null cells stably
expressing wt or mutant cMet were incubated in the presence
or absence of InlB (100 ng/ml) for increasing periods of time at
37 °C. After incubation, the cells were then chilled on ice to
prevent further receptor trafficking, and cMet remaining on the
cell surface was labeled specifically with a cMet-specific anti-
body under non-permeabilized conditions. Flow cytometry
analysiswas thenused to quantify the relative number of immu-
noreactive receptors remaining on the cell surface under these
conditions (Fig. 1E). All cell populations expressed similar lev-
els of surface cMet under control conditions (i.e. no receptor
internalization at 4 °C), consistent with their initial selection
based on similar levels of cell surface receptor expression (data
not shown). As expected, reduced levels of wt cMet were
detected on the cell surface relative to cells incubated in the
absence of InlB, consistent with ligand induced-receptor inter-
nalization. In contrast to wt cMet, higher cell surface levels of
FIGURE 1. cMet internalization requires phosphotyrosines 1349 and
1356.A, cMet signaling in stable cMet null (/) cells expressingwt, KinD, or
a mutant deficient in Grb2 and Gab1 binding (YF) was examined after incu-
bation with () or without () 100 ng/ml InlB for 15 min at 37 °C by IP and
Western analysis (IB) for expression of total protein (cMet, Cbl), cMet ubiquiti-
nation (Ub) and phosphorylation (P-Met), and Cbl phosphorylation using the
anti-phosphotyrosine antibody PY20. The positions of molecular mass mark-
ers are indicated (kDa). B, pulldown (PD) surface biotinylation assays verified
that wt and mutant cMet were expressed at comparable levels on the cell
surface. C, Grb2 bindingwas detected in null (/) cells stably expressingwt
but not mutant cMet in response to treatment with 100 ng/ml InlB. D, Gab1
was phosphorylated in response to treatmentwith () 100 ng/ml InlB in cells
expressing wt but not mutant cMet. E, cMet null (/) cells expressing wt or
the indicated cMet mutants were left untreated (0 min) or treated with 100
ng/ml InlB for 5, 10, or 20min at 37 °C. The cells were chilled to 4 °C, and cMet
on the cell surfacewas specifically labeledwith anti-cMet antibody andquan-
tifiedby flowcytometry. Results represented themean fluorescent intensities
normalized to untreated cells under each experimental condition from tripli-
cate experiments. Bars represent the means for data across all experiments
with S.E.
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YF-cMet and KinD-cMet were routinely detected at each time
point. After an initial decrease in detected cell surface levels of
KinD-cMet andYF-cMet at 5 and 10min, respectively, receptor
levels remained constant thereafter for up to 20 min of ligand
treatment. The initial reduction in the surface levels of cMet
could be the result of the constitutive internalization of cMet
consistent with our earlier studies (3) or steric hindrance of
antibody binding to cMet. We confirmed our flow cytometry
studies using Alexa-labeled InlB (Alexa-InlB) as a ligand to
examine the internalization of wt andmutant cMet by confocal
microscopy (supplemental Fig. S2). After incubation for 10min
at 37 °C in media containing Alexa-InlB, internalized ligand
was detected with co-internalized Texas Red-labeled Tfn in
cells expressing wt cMet. Conversely, decreased levels of inter-
nalized InlB were detected in cells expressing KinD cMet or the
cMetmutant lacking a functional Gab1/Grb2 binding site (YF).
Rather, large spots of InlB fluorescence were detected on the
surface of cells expressing YF-cMet. Clathrin-mediated Tfn
uptake was unaffected in null cells expressing YF-cMet or
KinD-cMet, consistent with a specific block in cMet internal-
ization rather than saturation of the clathrin-dependent endo-
cytic machinery (supplemental Fig. S1). Thus, activation of the
cMet-tyrosine kinase activity and subsequent recruitment of
one or more of the proteins that are known to associate with
phosphotyrosines 1349 and 1356 are required for cMet inter-
nalization through clathrin-coated pits.
Grb2 Is Required for cMet Internalization—Our data indicat-
ing the dependence on phosphotyrosines 1349 and 1356 in the
multisubstrate docking region for cMet internalization raised
the possibility that the adaptors Grb2 and/or Gab1 could be
required for this process. To test this idea we used specific
siRNAs to deplete T47D/cMet cells of endogenous Grb2.
T47D/cMet cells are a humanmammary epithelial cell line that
stably expresses human cMet on their surface and have been
extensively used on studies examining cMet signaling and
endocytosis in the past (3, 13, 14, 44). Endogenous Grb2 was
weakly detected byWestern analysis in T47D/cMet cells trans-
fected with Grb2-siRNAs (Fig. 2A). Conversely, comparable
levels of endogenous transferrin receptor, actin, and cMet were
observed in Grb2-depleted T47D/cMet cells as well as untrans-
fected cells, and T47D/cMet cells transfected with a control
siRNA, demonstrating the specificity of the siRNA treatment.
Western analysis confirmed that siRNA-mediated depletion of
Grb2 did not reduce cMet phosphorylation in response to InlB
(10min at 37 °C) (Fig. 2B). Conversely, cMet ubiquitination and
Cbl phosphorylation were reduced by Grb2 depletion. siRNA-
treated cells were coincubatedwith Tfn andHGF orAlexa-InlB
for 10min at 37 °C, and ligand internalization wasmeasured by
confocal microscopy. cMet internalization in response to HGF
or InlB was reduced 51.3 4.85 and 74.4 2.87%, respectively,
in Grb2-depleted cells versus cells transfected with a control
siRNA (Fig. 2C). Comparable levels of co-internalized Tfn were
detected in control and Grb2-depleted T47D/cMet cells, indi-
cating that loss of Grb2 led to a specific block in cMet internal-
ization and not a general defect in clathrin-mediated endocy-
tosis (Fig. 2C and supplemental Fig. S3). siRNA-mediated Grb2
depletion caused a comparable block in cMet endocytosis in
cMet null cells stably expressing wild type receptor, indicating
that endogenous Grb2 is required for cMet uptake in different
cell types (supplemental Fig. S4). We confirmed the require-
ment for Grb2 in cMet internalization using flow cytometry. As
expected, we observed higher levels of surface cMet in Grb2-
depleted T47D/cMet cells relative to cells transiently trans-
fected with a nonspecific control siRNA after receptor activa-
tionwith InlB (Fig. 2D). Thus, loss ofGrb2 led to a specific block
in HGF- and InlB-induced cMet internalization and not a gen-
eral inhibition in clathrin-mediated endocytosis.
Interactions Downstream of Grb2 Recruitment Mediate cMet
Internalization—We used targeted dominant negative Grb2
mutants to determinewhether the binding of Grb2 to cMet was
important for receptor endocytosis. Grb2 consists of a central
SH2 domain flanked by two SH3 domains. The central SH2
domainmediates Grb2 binding to phosphotyrosine 1356 in the
multisubstrate docking site of activated cMet and to the tyro-
sine-phosphorylated adaptor protein Shc. The SH3 domains of
Grb2mediate its binding to critical signaling molecules includ-
ing the adaptor Gab1 (56), cCbl (57, 58), and the large GTPase
dynamin (59). The mutations P49L and G203R in the N- and
C-terminal SH3 domains, respectively, (Fig. 3A), block these
interactions in a double Grb2 mutant (Grb2-mSH3). If Grb2 is
required for cMet internalization, we reasoned that in contrast
to wt Grb2, expression of a mutant expressing only the SH2
domain ofGrb2 (Grb2-SH2)would function as a dominant neg-
FIGURE2. siRNA-mediatedGrb2depletion inhibits InlB andHGF internal-
ization. A, lysates frommock-transfected (Un) T47D/cMet cells or cells trans-
fected with control (Con) or Grb2 siRNAs were examined byWestern analysis
for Grb2, transferrin receptor (TfR), actin and cMet expression. B, mock-trans-
fected T47D/cMet cells or cells transfected with the indicated siRNAs were
treated for 10 min at 37 °C with () or without () 100 ng/ml InlB. Cell
lysates were examined by Western analysis (IB) for expression of total
protein (cMet, Grb2, Cbl), phosphorylation IP cMet and Cbl (PY20), and
cMet ubiquitination (Ub). C, the relative amounts of internalized HGF, Alexa-
InlB, and Tfn (10min at 37 °C)were quantified by confocalmicroscopy. Values
represent the mean fluorescence intensity S.E. from four separate experi-
ments andareexpressedas apercentageof control values.D, T47D/cMet cells
transfectedwith control or Grb2-specific siRNAswere treatedwith 100 ng/ml
InlB for the indicated times at 37 °C, and surface cMet levels were quantified
by flow cytometry analysis as described in the legend to Fig. 1E.
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ative mutant and block the binding of endogenous Grb2 to
cMet. Conversely, the SH3 doublemutant (Grb2-mSH3)would
be unable to form productive complexes with downstream
effectors and, hence, function to impede cMet internalization
when expressed in cells. T47D/cMet cells were transfectedwith
wt or mutant Grb2 (Grb2-SH2, Grb2-mSH3) labeled at their C
termini with enhanced yellow fluorescent protein (EYFP) (Fig.
3A) to enable detection of the overexpressed proteins. The
presence of EYFP has been shown not to interfere with the
function of wt Grb2 or its mutants (22). Control Western anal-
ysis detected comparable levels of activated cMet in mock-
transfected T47D/cMet cells and in cells expressing wt or
mutantGrb2 (supplemental Fig. S5) in response to InlB. In con-
trast to wt Grb2, expression of Grb2-mSH3 and to a lesser
extent Grb2-SH2 resulted in reduced extracellular signal-regu-
lated kinase activation. The reduced activation of extracellular
signal-regulated kinase observed in cells expressing Grb2-SH2
was consistent with the lower transfection rate routinely
obtained using this construct (supplemental Fig. S5). The effect
of wt and mutant Grb2 on Alexa-InlB uptake in T47D/cMet
cellswas quantified using confocalmicroscopy.After treatment
with Alexa-InlB for 10 min at 37 °C to stimulate cMet inter-
nalization, comparable levels of internalized ligand were
detected in control cells expressing EYFP only and in cells
expressing wt Grb2 (Fig. 3B and supplemental Fig. S6). Con-
versely, an 84–90% decrease in the relative amount of internal-
ized Alexa-InlB was detected in cells expressing Grb2-SH2 or
Grb2-mSH3, indicating that functional interactions down-
stream of Grb2 binding are important for cMet internalization.
Cbl Ubiquitin Ligase Activity Is Required for cMet
Internalization—Consistent with our data demonstrating a
requirement for Grb2 in cMet internalization, we previously
reported that receptor endocytosis is impaired in cells overex-
pressing dominant negative dynamin (3). However, it remains
unclear which additional Grb2-mediated interactions are
required for the internalization of soluble InlBcMet or
HGFcMet complexes. Our initial studies focused on the E3
ubiquitin ligase Cbl for several reasons. Grb2-recuited Cbl
ubiquitin ligase activity has been implicated in the clathrin-de-
pendent internalization of EGFR in response to EGF (17–21).
Grb2 has been shown to constitutively associate with the E3
ubiquitin ligase Cbl (60–62) and is recruited to cMet in
response to receptor activation (4, 14). Overexpression of a Cbl
mutant encompassing the N-terminal TKB and RING finger
domains has been reported to decrease cMet internalization,
possibly by blocking recruitment of CIN85-endophilin com-
plexes to cMet (4). Although these studies demonstrated a
role for Cbl in cMet internalization, they focused only on the
adaptor functions of Cbl and did not examine the require-
ment for the ubiquitin ligase activity of Cbl for cMet inter-
nalization. Thus, the indirect recruitment of Cbl ubiquitin
ligase activity through Grb2 could contribute to Grb2 func-
tion in cMet endocytosis.
We tested the idea that the ubiquitin ligase activity of Cblwas
important for cMet internalization using confocal microscopy.
T47D/cMet cells were transfected with wt Cbl or Cbl mutants
defective in either ubiquitin ligase activity (70Z-Cbl) or binding
to phosphotyrosine 1003 (Cbl-G306E) (Fig. 4A). Previous stud-
ies have demonstrated that Cbl binds cMet and induces its
ubiquitination in response to HGF, whereas the ubiquitin
ligase-deficient mutant Cbl-70Z interacts with cMet but is
unable to induce receptor ubiquitination (4, 13, 14, 43). The
cells were allowed to co internalize TfnwithAlexa-InlB orHGF
for 10 min at 37 °C, and the relative amount of internalized
ligand was examined by confocal microscopy (supplemental
Fig. S7). cMet internalization was unaffected in mock-trans-
fected control cells and in cells expressing wt Cbl or G306E, a
mutant unable to bind RTKs directly. However, in cells overex-
pressing the ubiquitin ligase-deficient mutant 70Z-Cbl, inter-
nalized HGF and Alexa-InlB staining was reduced to 33.5 2.4
and 50.4  2.6% of control levels, respectively (Fig. 4B). To
confirm the requirement of Cbl-mediated ubiquitination for
cMet internalization, we took advantage of well characterized
ubiquitin mutants that have altered conjugation and binding
properties (Fig. 4C). Cbl functions to covalently attach monou-
biquitin to substrate proteins via the C-terminal glycine resi-
dues of ubiquitin. The ubiquitinmutantUbR lacks these glycine
residues important for substrate conjugation. However, UbR
retains the ability to interact with intracellular proteins harbor-
ing ubiquitin binding domains, including the ubiquitin-inter-
acting motif. Thus, when expressed in cells, UbR functions to
block the interaction of ubiquitinated proteins with proteins
harboring a ubiquitin-interacting motif (18). Using confocal
microscopy, we examined the effect of transiently expressing
mutant ubiquitin (UbR) on cMet internalization in T47D/cMet
cells. UbR containing the double mutation L8A,I44A (UbR-
L8A,I44A) that blocks the interaction of UbR with ubiquitin
FIGURE3. InteractionsdownstreamofGrb2are involved in cMet internal-
ization. A, schematic of EYFP-tagged wt or mutant (SH2, mSH3) Grb2 and
their binding properties. B, the relative amounts of internalizedAlexa-InlB (10
min at 37 °C) inmock-transfected T47D/cMet cells and in cells expressing the
indicated EYFP-tagged Grb2 proteins were quantified by confocal micros-
copy. Values represent themean fluorescence intensity S.E. from four sep-
arate experiments and are expressed as a percentage of control (mock-trans-
fected) values.
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interacting motifs was used as a
control (supplemental Fig. S8). As
shown in Fig. 4D, expression of UbR
reduced cMet internalization to
33.7  3.4% relative to mock-
transfected control cells or cells
expressing the double mutant
UbR-L8A,I44A. Tfn uptake was
unaffected in cells expressing UbR
or UbR-L8A,I44A. This is the first
report indicating that the ubiquitin
ligase activity of Cbl is important for
cMet internalization in response to
soluble InlB as well as HGF.
Recruitment of Cbl through the
SH2 Domain of Grb2 Supports cMet
Internalization—Our data indicat-
ing a role for Grb2 and the ubiquitin
ligase activity ofCbl for the internal-
ization of soluble ligand-cMet com-
plexes suggested that the recruit-
ment of a Grb2Cbl complex could
be important for cMet internaliza-
tion. To test this we transiently
transfected T47D/cMet siRNA-de-
pleted of endogenous Grb2 with a
chimeric protein in which wt Cbl
was taggedwith EYFP at itsN termi-
nus, and the SH2 domain of Grb2
was tagged at its C terminus (Cbl-
SH2) (22). In the absence of endog-
enous Grb2, Cbl recruitment to the
docking site of cMet would be pre-
dicted to occur via the Grb2-SH2
domain at the C terminus of the chi-
meric protein, thereby reversing the
inhibition of cMet endocytosis
imposed by Grb2 depletion. A sec-
ond mutant chimeric protein defi-
cient in cMet binding (Cbl-SH2/
R86A) (22) was used as a control
(Fig. 5A). In these studies, T47D/
cMet cells were co transfected with
Grb2-targeted siRNA and with Cbl-
SH2, Cbl-SH2/R86A, or mock-
transfected cells as a control. The
cells were allowed to co internalize
Alexa-InlB and HGF for 10 min at
37 °C. Given the low double trans-
fection rates routinely observed
using these constructs, we exam-
ined the relative amounts of inter-
nalized ligand using confocal
microscopy (Fig. 5B). Internalized
HGF was detected by co-staining
with an antibody specific for HGF.
Expression of the chimeric protein
Cbl-SH2 in Grb2-depleted cells
FIGURE 4. Cbl ubiquitin ligase activity is involved in cMet internalization. A, schematic of hemagglu-
tinin-tagged wt or mutant Cbl (70Z, G306E) and their binding properties. B, mock-transfected T47D/cMet
cells and T47D/cMet cells transiently expressing hemagglutinin-tagged wt or mutant Cbl were allowed to
internalize Alexa-InlB or 100 ng/ml HGF for 10 min at 37 °C, and the relative amounts of internalized
ligands were quantified by confocal microscopy. Internalized HGF was detected by staining cells with an
anti-HGF antibody. Values represent the mean fluorescence intensity  S.E. from four separate experi-
ments and are expressed as a percentage of control (mock-transfected) values. C, schematic of cMyc-
tagged wt ubiquitin (UbR GG), mutant ubiquitin (UbR) and the inactive variant UbR-L8A/I44A are shown.
D, the relative amounts of internalized Tfn and InlB in transfected T47D/cMet cells expressing the indi-
cated constructs were quantified using confocal microscopy. Values represent the mean fluorescence
intensity  S.E. from four separate experiments and are expressed as a percentage of control (mock-
transfected) values.
FIGURE 5. Rescue of cMet internalization in Grb2-depleted cells using a Cbl-Grb2/SH2 chimeric protein.
A, schematic of EYFP-taggedmutant Grb2 (R86A) deficient in cMet binding, wild type Cbl (Cbl wt), Cbl fused to
the SH2 (cMet binding) domain of Grb2 or amutant Grb2-SH2 domain (SH2/R86A). B, T47D/cMet cells were co
transfected with Grb2-specific siRNAs to deplete endogenous Grb2 and EYFP-tagged constructs as indicated.
The relative amounts of internalized Alexa-InlB and HGF were quantified by confocal microscopy. Values
represent themean fluorescence intensity S.E. from 4 separate experiments and are expressed as a percent-
age of control (mock-transfected) values.
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caused increased uptake of Alexa-InlB and HGF in Grb2-de-
pleted cells compared with Grb2-depleted cells expressing
EYFP only. Conversely, expression of the chimeric protein defi-
cient in cMet binding (Cbl-SH2/R86A) was not as effective at
rescuing cMet internalization in Grb2-depleted cells. Similarly,
overexpression of wt Cbl or Grb2/R86A (a Grb2 mutant defi-
cient in cMet binding) did not reverse the inhibitory effect of
siRNA-mediated Grb2 depletion on cMet internalization.
Together, these data suggest that the major role of Grb2 in
cMet endocytosis is to recruit Cbl to the receptor.
The Signaling Adaptor Gab1 Is Not Required for cMet
Internalization—In addition to binding Cbl, Grb2 has been
shown to bind Gab1, an adaptor protein that mediates almost
all of the signaling cascades downstream from activated cMet
including phosphatidylinositol 3-kinase, c-Jun N-terminal
kinase, and extracellular signal-regulated kinase signaling (for
review, see Ref. 63). Gab1 is recruited to cMet by two mecha-
nisms. The primary mechanism involves the indirect recruit-
ment of Gab1 to cMet via Grb2 (35, 38). In addition, Gab1 can
bind directly to phosphotyrosine 1349 in the multisubstrate
docking site of cMet (64). To examine the importance of Gab1
in cMet internalization, a Gab1-specific siRNA was used to
deplete T47D/cMet cells of endogenous Gab1. Western analy-
sis confirmed the specificity of the siRNA-mediated Gab1
knockdown in cells transfected with Gab1 but not a scrambled
control (Con) siRNA (Fig. 6A). Comparable levels of Cbl, actin,
Grb2, transferrin receptor, and cMet were detected in Gab1-
depleted cells as well as mock-transfected cells and cells trans-
fected with a control siRNA. Western analysis confirmed that
siRNA depletion of Gab1 did not inhibit ligand-induced cMet
phosphorylation and ubiquitination or Cbl phosphorylation
(Fig. 6B). To examine the effect of Gab1 depletion on cMet
internalization, siRNA-treated cells were incubated with InlB
(100 ng/ml for 10 min at 37 °C) to activate cMet signaling, and
the relative amounts of residual cell surface cMet were meas-
ured using flow cytometry (Fig. 6C). Comparable levels of cell
surface cMet were detected in control and Gab1-depleted cells,
indicating that siRNA-mediated knockdown of Gab1 did not
inhibit cMet internalization in response to InlB. Confocal
microscopy studies confirmed that cMet internalization in
response to InlB or HGF was not decreased in Gab1 depleted
T47D/cMet cells or cells transfectedwith a control siRNA (data
not shown). Thus, loss of Gab1 does not block clathrin-medi-
ated cMet internalization.
TheDirect Binding of Grb2 to theMultisubstrate Docking Site
of cMet Promotes Receptor Endocytosis—Asimilar role forGrb2
and Cbl in EGFR internalization has been reported (17, 18, 21,
22), suggesting a general role for these proteins in RTK endo-
cytosis. However, it is unclear whether Grb2 functions by
directly interacting with cMet at phosphotyrosine 1356. Alter-
natively, the ability of the adaptor Shc to recruit Grb2 indirectly
to cMet (56) may underlie the requirement for Grb2 in cMet
endocytosis. To distinguish between these possibilities, we gen-
erated a polyclonal cell line using cMet/ null cells expressing
moderate levels of the cMet mutant N1358H (NH-cMet).
N1358H is a well characterizedmutation that specifically inter-
feres with the direct binding of Grb2 to cMet with no measur-
able effect on the recruitment of other signaling or adaptor
molecules including Shc (29, 65). Surface biotinylation studies
confirmed that, like wt cMet, the mutant receptor NH-cMet
was expressed at the cell surface (Fig. 7A). GST pulldown assays
confirmed that recombinant Grb2 bound to wt cMet in
response to InlB. Conversely, Grb2 binding to NH-cMet was
inhibited under these conditions (Fig. 7B). cMet ubiquitination
and Cbl phosphorylation in response to InlB was detectable
in null cells expressing wt cMet but reduced in cells express-
ing the mutant NH-cMet (Fig. 7C). These data support the
conclusion that the direct binding of Grb2 to the docking site
of cMet is inhibited by the mutation N1358H. We next com-
pared the internalization properties of NH-cMet with the
wild type receptor. Using Alexa-InlB to stimulate cMet
internalization (10 min, 37 °C), we confirmed that cMet
internalization was reduced in cMet null cells stably express-
ing NH-cMet but not in cMet null cells stably expressing wt
cMet by confocal microscopy (Fig. 7D). To confirm our con-
focal studies, we used flow cytometry analysis to compare the
internalization properties of wt and NH-cMet. Cells were incu-
FIGURE 6. siRNA-mediated Gab1 depletion does not inhibit InlB- and
HGF-induced cMet internalization. A, Western analysis of lysates from
mock-transfected (Un) and T47D/cMet cells transfected with control (Con) or
Gab1 siRNAs confirmed specific knockdownofGab1.B, T47D/cMet cellswere
transfectedwith the indicated siRNAs after treatmentwith () or without ()
100ng/ml InlB for 10minat 37 °C. Equal amountsof lysateswereexaminedby
IP andWestern analysis (IB) for total protein (cMet, Gab1, andCbl), cMet phos-
phorylation (P-Met), ubiquitination (Ub), and Cbl phosphorylation (PY20) as
indicated.C, T47D/cMet cells transfectedwith control orGab1-specific siRNAs
were treated with 100 ng/ml InlB for the indicated times at 37 °C, and surface
cMet levels were quantified by flow cytometry analysis.
cMet Uptake Requires Grb2 and Cbl Ubiquitin Ligase Activity
JUNE 8, 2007•VOLUME 282•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 16771
 at U
CF H
ealth Sciences Library on Septem
ber 24, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
bated inmedia containing100ng/ml InlB for increasingperiods of
time at 37 °C and processed for flow cytometry. Under these con-
ditions, the cell surface levels of NH-cMet remained unaltered
over thecourseof theexperiment.Conversely, cell surface levels of
wt cMet decreased to 35.7 7.6% after treatment with 100 ng/ml
InlB for 20min (Fig. 7E).
In contrast to our results above, Shc has been reported to regu-
late EGFR internalization (66), consistent with a role for the indi-
rect recruitment of Grb2 for receptor internalization. To confirm
that Shc is dispensable for cMet inter-
nalization,weused a siRNAapproach
in cMet/ cells stably expressing wt
cMet. Western analysis detected
reduced levelsof all threeendogenous
Shcproteinsmeasuring 46, 52, and66
kDa in cells transfected with Shc-
siRNA but not in mock-transfected
cells or cells transfectedwith a scram-
bled control siRNA (Fig. 8A). A non-
specific immunoreactive band was
routinely detected using Shc-specific
antibodies, consistent with previous
reports using other cell lines (67).
Comparable levels of actin and Grb2
were detected in Shc-depleted cells as
well as mock-transfected cells and
cells transfected with a control
siRNA. We quantified the effects of
siRNA-mediated Shc depletion on
cMet internalization using flow
cytometry analysis. Comparable lev-
els of cell surface cMet were detected
in cells transfected with control or
Shc-siRNAs after treatment with 100
ng/ml InlB at all internalization times
(Fig. 8B), indicating that cMet inter-
nalization is not dependent on the
indirect recruitment of Grb2 through
the adaptor Shc.
DISCUSSION
It was unclear whether the regulatory mechanisms for clath-
rin-mediated endocytosis vary for different RTK subfamilies.
cMet and its oncogene TPR-Met are unique among RTKs in
that two key tyrosine residues in their C-terminal multisub-
strate docking sites mediate all of the biological and transform-
ing activities of these receptors. In this study we examined the
role of these tyrosines and their ability to bind specific signaling
proteins for the internalization of the proto-oncogene cMet.
Using variant forms of cMet with altered catalytic and binding
properties, we demonstrate that clathrin-dependent cMet
internalization is dependent on both the intrinsic kinase activ-
ity of the receptor and the recruitment of signalingmolecules to
phosphotyrosines 1349 and 1356 in the unique multisubstrate
docking site of cMet. Depletion of Gab1 using siRNA did not
inhibit cMet internalization. However, the levels of Gab1 were
reduced but not abrogated in these studies, suggesting that low
levels of Gab1 could be sufficient to allow cMet internalization.
In a separate study we detected comparable levels of internal-
ized cMet in mouse embryonic fibroblasts isolated from Gab1
null mice and a mouse embryonic fibroblast cell line isolated
from their wild type litter mates stably expressing wt cMet.3
Thus,we conclude that the recruitment of the signaling adaptor
Gab1 was dispensable for cMet internalization. Our studies are
the first to show a strict requirement for the ubiquitin ligase
3 N. Li, M. Lorinczi, K. Ireton, and L. A. Elferink, unpublished data.
FIGURE 7.Direct Grb2 recruitment is required for cMet internalization. A, pulldown (PD) surface biotinyla-
tion assays confirmed that cMet null (/) cells stably express comparable levels of wt cMet or cMet-N1358H
(NH), amutantdeficient inGrb2binding, at their surface.B, cMetnull (/) cells stably expressingwtormutant
cMet (NH) were treatedwith () or without () 100 ng/ml InlB for 10min at 37 °C. Equal amounts of cell lysates
were incubated with recombinant GST-Grb2 and examined by Western analysis (IB). Grb2 binding to mutant
NH-cMetwas inhibited in response to InlB treatment. C, total protein (cMet, Cbl), cMet ubiquitination (Ub), and
phosphorylation (P-Met) and Cbl phosphorylation (PY20) in response to InlB () were examined in lysates
prepared from cMet null (/) cells stably expressing wt ormutant cMet (NH) by IP andWestern analysis. The
positions of molecular mass markers are indicated (kDa). D, confocal microscopy detected reduced levels of
internalized Alexa-InlB but not Tfn in cMet null (/) cells stably expressing mutant cMet (NH). Values repre-
sent themean fluorescence intensity S.E. from four separate experiments and are expressed as a percentage
of control (wt cMet) values. E, surface cMet levels on cells expressingwt ormutant (NH) cMet were determined
after treatment with 100 ng/ml InlB for the indicated times at 37 °C and quantified by flow cytometry analysis.
Results represented the mean fluorescent intensities normalized to untreated cells (0 min) from triplicate
experiments. Bars represent the means for data across three experiments with S.E.
FIGURE 8. cMet internalization does not involve Shc.A, Western analysis of
lysates from mock-transfected (Un) and cMet null cells expressing wt cMet
transfected with control (Con) or Shc siRNAs for Shc, actin, and Grb2 con-
firmed specific knock down of the three family members of Shc. The asterisk
indicates a nonspecific immunoreactive band. B, cMet/ cells stably
expressingwt cMet were transfectedwith control or Shc specific siRNAs then
treatedwith 100 ng/ml InlB for the indicated times at 37 °C, and surface cMet
levels were quantified by flow cytometry analysis. Results are graphed as a
percentage of total surface cMet S.E. before internalization.
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activity of Cbl for the internalization of complexes formed
between cMet and two soluble receptor ligands, HGF and InlB.
Consistent with a role for Cbl ubiquitin ligase activity, overex-
pression of an ubiquitinmutant that could not be conjugated to
substrates yet retained the ability to bind to an ubiquitin inter-
acting motif blocked ligand-induced cMet internalization.
Together, our results broaden the roles of Grb2 and Cbl ubiq-
uitin ligase activity to cMet internalization, a receptor-tyrosine
kinase with unique structural and signaling characteristics.
A similar role for Grb2 has been reported for the EGFR.
EGFR internalization through clathrin-coated pits was specifi-
cally blocked in Grb2-depleted cells (17). The block in EGFR
internalization imposed byGrb2 depletionwas rescued by tran-
sient expression of a Grb2Cbl chimera (22). Overexpression of
Grb2-SH3 mutants deficient in binding downstream signaling
molecules inhibited the recruitment of EGFR to clathrin-
coated pits (18) and prevented the translocation of Grb2 with
activated EGFR into endocytic structures, presumably endo-
cytic transport vesicles (48). In a separate study, overexpression
of Grb2 with inactivating point mutations in the SH3 domains
inhibited EGF-induced coated pit formation, with negligible
effects on the downstream activation ofmitogen-activated pro-
tein kinase or phosphatidylinositol 3-kinase (19). Our studies
showing that Grb2-mediated internalization of cMet was
dependent on the ubiquitin ligase activity of Cbl are consistent
with several models for EGFR internalization in which the
Grb2Cbl complex likely functions to couple distinct stages of
RTK endocytosis (20, 22, 68).
Themultiadaptor Gab1 plays a critical role in cMet signaling
by providing a scaffold for the simultaneous activation of sev-
eral downstream signaling cascades including the activation of
phosphatidylinositol 3-kinase, c-Jun N-terminal kinase, and
extracellular signal-regulated kinase signaling (for review, see
Ref. 63). Our data showing that the recruitment of Gab1 to
cMet is dispensable for receptor internalization are consistent
with our previous report that phosphatidylinositol 3-kinase sig-
naling was not required for cMet endocytosis (3). cMet inter-
nalizationwas unaffected by overexpression of a dominant neg-
ative mutant for the p85 subunit of phosphatidylinositol
3-kinase. Similarly, no differences in the internalization prop-
erties of cMet were observed in T47D/cMet cells treated with
the phosphatidylinositol 3-kinase inhibitors LY294002 orwort-
mannin (3). Thus, although Gab1 likely regulates the intensity
and duration of cMet signaling, this does not appear to occur at
the level of receptor internalization.
The recruitment ofGrb2 directly or indirectly via the adaptor
Shc to phosphotyrosine 1356 of cMet is essential for cell trans-
formation and experimental metastases in response to onco-
genicMet (69). The ability of Shc to form a stable complex with
Grb2 in response to HGF (56) and EGF (70, 71) suggested that
Grb2 recruited indirectly via Shc could regulate RTK endocy-
tosis. Our data showing that cMet internalization was impaired
by the N1358Hmutation suggested that the direct recruitment
of Grb2 to cMet rather than Grb2 recruited indirectly through
Shc mediates cMet internalization, since Shc binding is unaf-
fected by the N1358H mutation (29, 65). Consistent with this
idea, siRNA-mediated Shc depletion did not interfere with
cMet internalization through clathrin-coated pits. Thus, in
light of our observations, we propose that Grb2 bound directly
to cMet is indispensable for receptor endocytosis. In contrast to
cMet, Shc has been reported to play a role in EGF-induced
EGFR internalization (66, 72). EGF has been shown to promote
the formation of a complex between wild type Shc and the
adapter complexAP2 that is recruited to phosphotyrosine 1148
of the EGFR. Consistent with a role for Shc in EGFR endocyto-
sis, the internalization rate constant of an EGFR truncation
mutant lacking the region encompassing phosphotyrosine
1148 was significantly slower than that observed for the wild
type receptor (73). Thus, themode ofGrb2 recruitment appears
to diverge for cMet versus EGFR internalization, suggesting
that distinct subsets of Grb2-mediated interactions are
involved in the clathrin-dependent internalization of different
RTKs.
The precise mechanism by which Cbl regulates cMet inter-
nalization and RTK endocytosis in general remains controver-
sial. Cbl can be viewed as a bimodal molecule that functions as
an adaptor protein that physically links Cbl/cMet complexes to
the endocytic machinery (4) and as an E3 ubiquitin ligase to
ubiquitinate cMet (13, 14) and its associated endocytic compo-
nents. Although Grb2 and Cbl ubiquitin ligase activity was
recently reported to be important for L. monocytogenes infec-
tion (5), these studies focused on the internalization of Listeria
expressing surface anchored InlB and not soluble InlB. More-
over, these studies did not examine cMet internalization
directly but instead monitored bacterial engulfment. A role for
Cbl as an adaptor that links HGF-activated cMet to the
endophillin-CIN85 complex (4) has been clearly demonstrated.
In these studies inhibition of complex formation using domi-
nant interfering forms of endophilin, CIN85, or Cbl was suffi-
cient to inhibit cMet internalization and enhance cMet signal-
ing. However, these studies did not address the requirement for
Cbl ubiquitin ligase activity in this event or the mode of Cbl
recruitment to cMet. Our studies showing that expression of a
Cbl mutant deficient in ubiquitin ligase activity blocks cMet
internalization and that a Grb2Cbl chimera rescues receptor
endocytosis in cells depleted of endogenousGrb2 are the first to
show a definitive role for Cbl ubiquitin ligase activity in this
process. Moreover, our studies indicate that Grb2 functions as
a critical intermediary for Cbl ubiquitin ligase activity in the
internalization of soluble InlBcMet and HGFcMet complexes.
Cbl has been shown to mediate ubiquitination of cMet in
response to HGF (43) in a process that involves the phosphoty-
rosine 1003 residue in the juxtamembrane region of cMet (13,
14, 42, 74). The observation that internalization of an ubiquiti-
nation-deficient Y1003F-cMet mutant is unaffected implies
that receptor ubiquitination may not be a critical determinant
for receptor internalization. Rather, Cbl-mediated ubiquitina-
tion of cMet via phosphotyrosine 1003 is important for degra-
dation of the internalized receptor (13). Because the Y1003F-
cMet was weakly ubiquitinated, we cannot rule out the
possibility that different levels of, or sites of cMet ubiquitina-
tion contribute to distinct steps for cMet endocytic trafficking.
Alternatively, clathrin-dependent internalization and receptor
degradation may be regulated by the indirect recruitment of
Cbl via Grb2 to phosphotyrosine 1356 versus Cbl recruited
directly to phosphotyrosine 1003.
cMet Uptake Requires Grb2 and Cbl Ubiquitin Ligase Activity
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In conclusion our data demonstrate a strict requirement for a
specific subset of Grb2-mediated interactions for cMet inter-
nalization from the cell surface. The direct binding of Grb2 to
cMet is essential for receptor internalization. Moreover, endo-
cytosis of soluble InlBcMet and HGFcMet complexes is
dependent on the E3 ubiquitin ligase activity of Cbl and does
not involve the Grb2 binding partner Gab1. Thus, Grb2 func-
tions as an important intermediary for linking ligand-activated
cMet with the ubiquitin ligase activity of Cbl for receptor inter-
nalization via clathrin-coated pits.
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